HRMY (Harmony Biosciences Holdings) Non Operating Income: $-0.4 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HRMY Harmony Biosciences Holdings Inc HRMY
96 GF Score
Price $41.10
GF Value $47.14
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Harmony Biosciences Holdings Non Operating Income?

Harmony Biosciences Holdings HRMY -1.25% 96 Non Operating Income is $-0.4 Mil as of Jun. 2026. GuruFocus rates HRMY with a GF Score™ of 96/100 and a GF Value™ of $47.14 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Non Operating Income is income or expense that comes from miscellaneous sources. Harmony Biosciences Holdings's Non Operating Income for the three months ended in Jun. 2026 was $-0.1 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 was $-0.4 Mil.

Harmony Biosciences Holdings Non Operating Income Related Terms

Harmony Biosciences Holdings Non Operating Income Historical Data

* Premium members only.

The historical data trend for Harmony Biosciences Holdings's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Harmony Biosciences Holdings Non Operating Income Chart

Harmony Biosciences Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Non Operating Income
Get a 7-Day Free Trial -26.13 0.17 -9.61 -0.07 -0.68

Harmony Biosciences Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.19 -0.11 -0.11 -0.13 -0.05
HRMY
96GF Score
Harmony Biosciences Holdings Inc HRMY
Non Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Harmony Biosciences Holdings Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Non Operating Income →
What does a Non Operating Income of $-0.4 Mil mean?
Harmony Biosciences Holdings (HRMY) has a Non Operating Income of $-0.4 Mil as of Jun. 2026. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Harmony Biosciences Holdings and its competitors.
Is Harmony Biosciences Holdings' Non Operating Income too high?
Harmony Biosciences Holdings' current Non Operating Income is $-0.4 Mil. Overall, Harmony Biosciences Holdings has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Harmony Biosciences Holdings' Non Operating Income compare to OCUL and MLYS?
Harmony Biosciences Holdings' Non Operating Income of $-0.4 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Non Operating Income for a Biotechnology company?
A good Non Operating Income depends on the Biotechnology industry context. However, Non Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Non Operating Income mean?
A high Non Operating Income can signal that a stock is expensive relative to its fundamentals. Non-operating Income represents the amount of income from one-time, nonrecurring events. View historical data on Harmony Biosciences Holdings and its competitors. Harmony Biosciences Holdings's current Non Operating Income is $-0.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Harmony Biosciences Holdings stock overvalued right now?
Based on GuruFocus' analysis, Harmony Biosciences Holdings (HRMY) is currently considered Modestly Undervalued. The stock's GF Value™ is $47.14, compared to a current price of $41.10 — trading 12.8% below its estimated fair value. The current Non Operating Income is $-0.4 Mil. Harmony Biosciences Holdings' overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Non Operating Income calculated?
Non Operating Income is calculated from a company's financial statements. For Harmony Biosciences Holdings (HRMY), the current Non Operating Income is $-0.4 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Harmony Biosciences Holdings (HRMY) Overvalued in 2026?

Based on GuruFocus' analysis, Harmony Biosciences Holdings stock appears to be undervalued. The current stock price of $41.10 is trading 12.8% below its estimated GF Value™ of $47.14. GuruFocus considers Harmony Biosciences Holdings to be Modestly Undervalued.

Key valuation signals for HRMY:

  • Non Operating Income: $-0.4 Mil
  • GF Value™: $47.14 vs. price of $41.10 (12.8% below fair value)
  • GF Score™: 96/100 with 4 warning signs

No single metric tells the full story. See the HRMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Harmony Biosciences Holdings Business Description

Address 630 W. Germantown Pike, Suite 215, Plymouth Meeting, PA, USA, 19462
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
96GF Score

Get the complete analysis for HRMY

Non Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$41.10
Price
$47.14
GF Value